The sale followed a conversion-for-sale event, reducing direct holdings to zero but retaining indirect equity exposure.
Insight Holdings Group sold 426,000 shares of Hinge Health (NYSE:HNGE) for $38.4 million on July 7 and July 9, 2026, per an SEC filing. The transaction occurred at a weighted average price of $90.21, reflecting a 101% one-year return for the stock.
Hinge Health’s shares closed at $89.92 on July 9, 2026, after the sale. The company reported trailing twelve-month revenue of $646.3 million and a net loss of $510.3 million, with a market capitalization of $6.8 billion as of July 8, 2026.
While the sale eliminated Insight Holdings’ direct Class A Common Stock holdings, the firm retains derivative securities, maintaining indirect exposure to the company.